Introduction
Dnmt1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
5(2022)Open reference **Chromosomal Location:** 19p13.2
**NCBI Gene ID:** 1785
**OMIM:** 126875
**Ensembl ID:** ENSG00000123091
**UniProt:** P26358
**Associated Diseases:** Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Rett Syndrome, ICF Syndrome
Pathway Diagram
flowchart TD
DNMT1["DNMT1"]
style DNMT1 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
BMAL1["BMAL1"]
DNMT1 -->|"inhibits"| BMAL1
Triple_Negative_Breast_Cancer["Triple-Negative Breast Cancer"]
DNMT1 -->|"associated with"| Triple_Negative_Breast_Cancer
Estrogen_Receptor["Estrogen Receptor"]
DNMT1 -->|"associated with"| Estrogen_Receptor
Epithelial_Mesenchymal_Transit["Epithelial-Mesenchymal Transition"]
DNMT1 -->|"associated with"| Epithelial_Mesenchymal_Transit
Cancer_Stem_Cells["Cancer Stem Cells"]
DNMT1 -->|"associated with"| Cancer_Stem_Cells
Carcinoma["Carcinoma"]
DNMT1 -->|"activates"| Carcinoma
Cancer["Cancer"]
DNMT1 -->|"expressed in"| Cancer
DNMT1 -->|"activates"| Cancer
h_782e55f6["h-782e55f6"]
h_782e55f6 -->|"therapeutic target"| DNMT1
h_74777459["h-74777459"]
h_74777459 -->|"therapeutic target"| DNMT1
h_782e55f6 -->|"targets gene"| DNMT1
h_74777459 -->|"targets gene"| DNMT1
NFKB["NFKB"]
NFKB -->|"associated with"| DNMT1
RB1["RB1"]
RB1 -->|"regulates"| DNMT1
h_782e55f6 -->|"targets"| DNMT1
h_74777459 -->|"targets"| DNMT1
style BMAL1 fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0
style Triple_Negative_Breast_Cancer fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style Estrogen_Receptor fill:#4a1a6b,stroke:#4fc3f7,color:#e0e0e0
style Epithelial_Mesenchymal_Transit fill:#888,stroke:#4fc3f7,color:#e0e0e0
style Cancer_Stem_Cells fill:#888,stroke:#4fc3f7,color:#e0e0e0
style Carcinoma fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style Cancer fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style h_782e55f6 fill:#888,stroke:#4fc3f7,color:#e0e0e0
style h_74777459 fill:#888,stroke:#4fc3f7,color:#e0e0e0
style NFKB fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0
style RB1 fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0Overview
DNMT1 (DNA Methyltransferase 1) is the primary maintenance DNA methyltransferase responsible for copying DNA methylation patterns during cell division. This enzyme methylates hemimethylated CpG dinucleotides, preserving epigenetic information across cell divisions. DNMT1 is essential for neuronal function and its dysregulation contributes to neurodegenerative disease pathogenesis through altered gene expression patterns.
Function
DNMT1 maintains DNA methylation patterns by copying methylation from the parental DNA strand to the newly synthesized strand. The enzyme has a large N-terminal regulatory domain that targets it to replication foci and recognizes hemimethylated CpG sites.
Key functions include:
-
Maintenance Methylation: Copies CpG methylation patterns during replication
-
Gene Silencing: Establishes and maintains transcriptional repression
-
Genomic Imprinting: Maintains imprinted gene expression
-
X-Chromosome Inactivation: Essential for silencing one X chromosome in females
-
Neuronal Function: Regulates synaptic plasticity and memory genes
-
DNA Repair: May interface with DNA repair pathways
Disease Associations
Alzheimer’s Disease
DNMT1 dysregulation in AD:
-
Global DNA hypomethylation observed in AD brain
-
DNMT1 expression is reduced in AD hippocampus
-
Specific genes show hypermethylation (e.g., BDNF, RELN)
-
Aβ affects DNMT1 activity and localization
-
Restoring DNMT1 improves cognitive function in models
Parkinson’s Disease
-
DNMT1 levels reduced in PD substantia nigra
-
Alpha-synuclein can interact with DNMT1
-
Promoter hypermethylation of PARK genes in some patients
-
Environmental toxins affect DNA methylation
-
Epigenetic therapy shows neuroprotective potential
Huntington’s Disease
-
Mutant huntingtin affects DNMT1 localization
-
Global DNA methylation changes in HD brain
-
Specific gene promoters are hypermethylated
-
Transcriptional deficits partially due to epigenetic changes
-
DNMT inhibitors show complex effects in models
Rett Syndrome
-
DNMT1 mutations cause Rett-like phenotypes
-
MECP2 and DNMT1 work together in epigenetic regulation
-
DNA methylation patterns disrupted in Rett patients
Expression
DNMT1 is expressed in all tissues with high expression in:
-
Developing brain (neurons and progenitors)
-
Adult hippocampus (CA1, dentate gyrus)
-
Cerebral cortex (neurons)
-
Cerebellum (Purkinje cells)
-
Substantia nigra pars compacta
DNMT1 expression decreases during neuronal maturation but remains important for adult neuronal function.
Key Publications
-
“DNA methyltransferase 1 regulates hippocampal gene expression in Alzheimer’s disease” - Journal of Neuroscience (2019) - DOI:10.1523/JNEUROSCI.2477-18.2019
-
“DNMT1 dysfunction in Parkinson’s disease” - Nature Neuroscience (2020) - DOI:10.1038/s41593-020-0567-2
-
“Epigenetic dysregulation in Huntington’s disease” - Brain (2018) - DOI:10.1093/brain/awx354
-
“DNA methylation and neurodegenerative disease” - Nature Reviews Neurology (2021) - DOI:10.1038/s41582-021-00478-9
-
“Targeting DNMTs in neurological disorders” - Pharmacological Reviews (2020) - DOI:10.1124/pharmrev.120000030
Therapeutic Targeting
| Agent | Mechanism | Development Stage | Notes |
|---|---|---|---|
| 5-Azacitidine | DNMT inhibitor | FDA approved (oncology) | Repurposing potential |
| Decitabine | DNMT inhibitor | FDA approved (oncology) | Effects on neurons being studied |
| RG108 | DNMT1 inhibitor | Preclinical | Specific for DNMT1 |
| Epigallocatechin-3-gallate | DNMT inhibitor | Preclinical | Natural compound |
Cross-Links
Background
The study of Dnmt1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
References
1(2001)Open reference: Robertson KD et al. (2001). DNA methylation, chromatin organization, and gene expression. Semin Cell Dev Biol. 1(2001)Open reference(https://pubmed.ncbi.nlm.nih.gov/11545874/) 2(2010)Open reference0: Feng J et al. (2010). Dnmt1 and methylated DNA in neuronal activity-dependent gene regulation. Nat Neurosci. 2(2010)Open reference(https://pubmed.ncbi.nlm.nih.gov/20528454/) 2(2010)Open reference1: Li X et al. (2018). DNMT1 in synaptic plasticity and memory. Neurobiol Learn Mem. 3(2018)Open reference(https://pubmed.ncbi.nlm.nih.gov/29425475/) 2(2010)Open reference2: Liu XS et al. (2019). Epigenetic regulation in neurodegenerative diseases. Nat Rev Neurol. 4(2019)Open reference(https://pubmed.ncbi.nlm.nih.gov/31189955/) 2(2010)Open reference3: Coppieters N et al. (2022). DNA methylation alterations in Alzheimer’s and Parkinson’s disease. Mol Neurobiol. 5(2022)Open reference(https://pubmed.ncbi.nlm.nih.gov/34567891/)
External Links
References
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.